The results in our study showed that the inhibition of NAF-1 can effectively inhibit the EMT and the stem cell characteristics of pancreatic cancer cells, suggesting that NAF-1 intervention may be an effective compound for inhibiting pancreatic cancer metastasis by targeting PCSCs and EMT. The gene discussed is NAF1; the disease is familial pancreatic carcinoma.